posted on 2014-06-27, 00:00authored byLouis-Félix Nothias-Scaglia, Pascal Retailleau, Julien Paolini, Christophe Pannecouque, Johan Neyts, Vincent Dumontet, Fanny Roussi, Pieter Leyssen, Jean Costa, Marc Litaudon
Bioassay-guided purification of an
EtOAc extract of the whole plant
of Euphorbia amygdaloides ssp. semiperfoliata using a chikungunya virus-cell-based assay led to the isolation
of six new (1–4, 9,
and 10) and six known (5–7, 8, 11, and 12) jatrophane
esters. Their planar structures and relative configurations were determined
by extensive spectroscopic analysis, and their absolute configurations
by X-ray analysis. These compounds were investigated for selective
antiviral activity against chikungunya virus (CHIKV), Semliki Forest
virus, Sindbis virus, and HIV-1 and HIV-2 viruses. Compound 3 was found to be the most potent and selective inhibitor
of the replication of CHIKV and of HIV-1 and HIV-2 (EC50 = 0.76, IC50 = 0.34 and 0.043 μM, respectively).
A preliminary structure–activity relationship study demonstrated
that potency and selectivity are very sensitive to the substitution
pattern on the jatrophane skeleton. Although replication strategies
of CHIK and HIV viruses are quite different, the mechanism of action
by which these compounds act may involve a similar target for both
viruses. The present results provide additional support for a previous
hypothesis that the anti-CHIKV activity could involve a PKC-dependent
mechanism.